ITAF <sub>45</sub> is a pervasive <i>trans</i> -acting factor for picornavirus Type II IRES elements

M Michael A. Bellucci M Mehdi Amiri S Stephen Berryman (The Pirbright Institute) A Andia Moshari (Department of Biochemistry, McGill University) C Collins Oduor Owino (Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University) R Rutger D. Luteijn (Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University) T Tobias J. Tuthill (The Pirbright Institute) Y Yuri Svitkin (Department of Biochemistry, McGill University) G Graham J. Belsham (Department of Veterinary and Animal Sciences, University of Copenhagen) F Frank J. M. van Kuppeveld N Nahum Sonenberg

Abstract

Viruses have evolved elaborate mechanisms to hijack the host mRNA translation machinery to direct viral protein synthesis. Picornaviruses, whose RNA genome lacks a cap structure, inhibit cap-dependent mRNA translation, and utilize an internal ribosome entry site (IRES) in the RNA 5′ untranslated region to recruit the 40S ribosomal subunit. IRES activity is stimulated by a set of host proteins termed IRES trans -acting factors (ITAFs). The cellular protein ITAF 45 (also known as PA2G4 or EBP1) was documented as an essential ITAF for foot-and-mouth disease virus (FMDV), with no apparent role in cell-free systems for encephalomyocarditis virus (EMCV) and Theiler’s murine encephalomyelitis virus (TMEV), which are closely related viruses harboring similar IRES elements. Here, we demonstrate that ITAF 45 is a pervasive host factor for picornaviruses containing a Type II IRES. CRISPR/Cas9 knockout of ITAF 45 in several human cell lines conferred resistance to infection with FMDV, EMCV, TMEV, and equine rhinitis A virus (ERAV). We show that ITAF 45 enhances initiation of translation on Type II IRESs in cell line models. This is mediated by the C-terminal lysine-rich region of ITAF 45 known to enable binding to viral RNA. These findings challenge previous reports of a restricted role for ITAF 45 in FMDV infection, thus positioning ITAF 45 as a potential antiviral target for various animal viruses and emerging human cardioviruses.

Article Details

Volume / Issue Vol. 122, Issue 33
Published August 19, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (11)

M

Michael A. Bellucci

M

Mehdi Amiri

S

Stephen Berryman

The Pirbright Institute

A

Andia Moshari

Department of Biochemistry, McGill University

C

Collins Oduor Owino

Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University

R

Rutger D. Luteijn

Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University

T

Tobias J. Tuthill

The Pirbright Institute

Y

Yuri Svitkin

Department of Biochemistry, McGill University

G

Graham J. Belsham

Department of Veterinary and Animal Sciences, University of Copenhagen

F

Frank J. M. van Kuppeveld

N

Nahum Sonenberg